Navigation Links
Parallel6 Named One of the 2017 Top 10 eClinical Trial Management Solution Providers by Pharma Tech Outlook
Date:4/20/2017

Parallel6™, the leader in mClinical™ technologies for improving patient enrollment, engagement, and management of clinical trials worldwide, announced today that they were named one of the 2017 Top 10 eClinical Trial Management Solution Providers by Pharma Tech Outlook magazine, which covers the latest developments in the pharmaceutical industry.

“We take pride in honoring Parallel6 as one of the top 10 companies that are specializing in providing eClinical Trial Management solutions for Pharmaceutical Companies,” said Stacey Smith, Managing Editor of Pharma Tech Outlook. “The team at Parallel6 has developed a technology that supersedes the current technology used in clinical trials and bridges the gaps formed in patient interaction on a daily basis.”

The Clinical6™ platform is an end-to-end solution that empowers potential clinical trial participants to digitally qualify, consent, enroll, and engage in a clinical trial using any internet enabled device, virtually eliminating delays, errors, and other issues. Clinical6 operates in a secure HIPAA compliant cloud, is 21 CFR Part 11 / Annex 11 compliant and has been independently audited.

“We are excited to see the continued momentum behind Clinical6. To date the top pharmaceutical companies and CROs have recognized how our technology platform is revolutionizing the way clinical trials are conducted. Our platform gives clinical trial stakeholders real-time access to the data they need to make informed decisions quicker,” said Allan Camaisa, CEO and Chairman of Parallel6.

“Clinical6 is a unified clinical platform that enables virtual, hybrid, and site-based clinical studies in multi-language, multi-country configurations anywhere in the world,” said President and CTO | Founder of Parallel6, David Turner.

For more information on how Clinical6 is leveraging mobile technologies to streamline clinical trials, check out our recent webinars here.

About Parallel6
Parallel6™, is an innovative software as a service provider of mobile enrollment and engagement solutions for clinical research, health, and public sector organizations. Clinical6™ is an mClinical™ platform for patient enrollment, engagement, and management of clinical trials worldwide. Additional solutions include GovReach™ for government agencies. GovReach accelerates government-to-citizen and internal government digital efficiency, transparency, and engagement. The firm’s headquarters is in San Diego, CA with additional offices in Washington D.C. For more information, visit http://www.parallel6.com/.

About Pharma Tech Outlook
Published from Fremont, California, Pharma Tech Outlook is a print magazine that covers most important and latest developments in pharmaceutical industry. A panel of experts and members of Pharma Tech Outlook’s editorial board selected and finalized the “Top 10 eClinical Trial Management Solution Providers 2017” and shortlisted the best vendors and consultants. For more info:  http://www.pharmatechoutlook.com

Read the full story at http://www.prweb.com/releases/2017/04/prweb14260508.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Cambridge Semantics Named 2013 SIIA CODiE Award Finalist
2. Bright Cluster Manager Named Bio-IT World Conference "Best in Show" Finalist
3. Life Technologies Chairman And CEO Gregory T. Lucier Named Penn State Outstanding Engineering Alumnus
4. Roberto DellOro Named Director of LMUs Bioethics Institute
5. Serial Entrepreneur Ken Malone Named BHI Entrepreneur-in-Residence to Offer Commercialization Guidance to Start-Ups Based on UM Discoveries
6. Street Named After EMCO High Voltage Corporation
7. Health Decisions CEO Michael Rosenberg Named a Business Leader Top Entrepreneur for 2013
8. CellHealth Institute is Named 2013 Edison Award Winner
9. St. Jude scientist named Howard Hughes Medical Institute investigator
10. Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group
11. Superior Controls of Seabrook, NH named Business of the Year for 2013 by Business NH Magazine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/11/2017)... ... August 11, 2017 , ... A staple in the community for ... will incorporate important key elements including a new digital marketing strategy and updated logo. ... them, Bill Miller has partnered with the South Texas Blood & Tissue Center for ...
(Date:8/11/2017)... (PRWEB) , ... August 11, 2017 , ... ... food production, and, in particular, more natural alternatives to synthetic ingredients,” said Matt ... of Third Wave, with the established manufacturing presence and know-how of Biorigin will ...
(Date:8/10/2017)... ... August 09, 2017 , ... Teachers from three Philadelphia ... August 14th through the 16th, the University City Science Center will kick off ... 2016, provides Philadelphia-based middle school educators an opportunity for professional development related to ...
(Date:8/10/2017)... ... ... Each year in the United States more than 300,000 people are hospitalized for ... even worse, the one-year mortality rate is high, ranging from 12 percent to 37 ... Medical Center (Sacramento) and Second Xiangya Hospital of the Central-South University (Hunan, China) might ...
Breaking Biology Technology:
(Date:4/19/2017)... The global military biometrics market ... by the presence of several large global players. The ... major players - 3M Cogent, NEC Corporation, M2SYS Technology, ... 61% of the global military biometric market in 2016. ... military biometrics market boast global presence, which has catapulted ...
(Date:4/17/2017)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... its 2016 Annual Report on Form 10-K on Thursday April 13, ... ... the Investor Relations section of the Company,s website at http://www.nxt-id.com ... http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/13/2017)... April 13, 2017 According to a new market ... Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, ... Market is expected to grow from USD 14.30 Billion in 2017 to ... of 17.3%. ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):